Roivant Sciences Ltd. Common Shares vs Revolution Medicines Inc. Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 4,855,734). Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ROIV | RVMD | |
|---|---|---|
Market Cap | $24.72B | $40.32B |
Volume | 6,279,442 | 4,855,734 |
Sector | Health | Health |
52-Week High | $41.81 | $221.15 |
52-Week Low | $16.04 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $20.99B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →